Skip to main content
Erschienen in: European Journal of Pediatrics 11/2010

01.11.2010 | Original Paper

Prevalence and risk factors for vitamin D deficiency among healthy infants and young children in Sacramento, California

verfasst von: Lisa Liang, Caroline Chantry, Dennis M. Styne, Charles B. Stephensen

Erschienen in: European Journal of Pediatrics | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

This cross-sectional study assessed vitamin D status of healthy infants and young children undergoing routine care in a medical center pediatric clinic in Sacramento, CA, and evaluated associations of status with markers of vitamin D function. Such data have not recently been reported from similar locations with sunny climates that should minimize risk of deficiency. Exposures included diet, supplement use, and sun exposure, and outcomes included plasma 25-hydroxy vitamin D (25[OH]D), parathyroid hormone (PTH), bone-specific alkaline phosphatase, and eight markers of immune activation. The median age of the 173 subjects was 12 months (range, 6–19); 49% were female. The median 25(OH)D was 85 nmol/l (range, 9–198); five subjects (2.9%) had <27.5 nmol/l, indicative of deficiency; 14 (8.1%) had <50 nmol/l, and 49 (28.3%) had <75 nmol/l. Most subjects (154; 89%) received some vitamin-D-fortified cow’s milk or formula while 19 (11%) received breast milk as the only milk source. Breastfeeding was associated with risk of vitamin D deficiency (p < 0.001). Subjects with 25(OH)D <27.5 nmol/l had elevated PTH (p = 0.007). Only four of 35 breastfed infants (11%) consuming <500 ml/day vitamin-D-fortified formula or milk received vitamin D supplements. Plasma interleukin (IL)-1β was significantly higher (p = 0.036) in infants in the highest vs. lowest 25(OH)D decile. In conclusion, this study demonstrates that vitamin D deficiency with elevated PTH remains a risk for breastfed subjects not receiving supplemental vitamin D even in a region with a sunny, temperate climate. Strategies to improve supplementation should be sought.
Literatur
1.
Zurück zum Zitat American Academy of Pediatrics. Committee on Environmental Health (1999) Ultraviolet light: a hazard to children. Pediatrics 104:328–333CrossRef American Academy of Pediatrics. Committee on Environmental Health (1999) Ultraviolet light: a hazard to children. Pediatrics 104:328–333CrossRef
3.
Zurück zum Zitat Bhalla AK, Amento EP, Krane SM (1986) Differential effects of 1, 25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 98:311–322CrossRefPubMed Bhalla AK, Amento EP, Krane SM (1986) Differential effects of 1, 25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 98:311–322CrossRefPubMed
4.
Zurück zum Zitat Bischoff-Ferrari HA, Giovannucci E, Willett WC et al (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMed Bischoff-Ferrari HA, Giovannucci E, Willett WC et al (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84:18–28PubMed
5.
Zurück zum Zitat Boonstra A, Barrat FJ, Crain C et al (2001) 1Alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167:4974–4980PubMed Boonstra A, Barrat FJ, Crain C et al (2001) 1Alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167:4974–4980PubMed
6.
Zurück zum Zitat Cantorna MT, Mahon BD (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229:1136–1142 Cantorna MT, Mahon BD (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229:1136–1142
7.
Zurück zum Zitat Cranney A, Horsley T, O’Donnell S et al (2007) Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep):1–235 Cranney A, Horsley T, O’Donnell S et al (2007) Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep):1–235
8.
Zurück zum Zitat Gartner LM, Greer FR (2003) Prevention of rickets and vitamin D deficiency: new guidelines for vitamin D intake. Pediatrics 111:908–910CrossRefPubMed Gartner LM, Greer FR (2003) Prevention of rickets and vitamin D deficiency: new guidelines for vitamin D intake. Pediatrics 111:908–910CrossRefPubMed
9.
Zurück zum Zitat Gessner BD, Plotnik J, Muth PT (2003) 25-Hydroxyvitamin D levels among healthy children in Alaska. J Pediatr 143:434–437CrossRefPubMed Gessner BD, Plotnik J, Muth PT (2003) 25-Hydroxyvitamin D levels among healthy children in Alaska. J Pediatr 143:434–437CrossRefPubMed
10.
Zurück zum Zitat Gordon CM, Feldman HA, Sinclair L et al (2008) Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med 162:505–512CrossRefPubMed Gordon CM, Feldman HA, Sinclair L et al (2008) Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med 162:505–512CrossRefPubMed
11.
Zurück zum Zitat Greer FR (2004) Issues in establishing vitamin D recommendations for infants and children. Am J Clin Nutr 80:1759S–1762SPubMed Greer FR (2004) Issues in establishing vitamin D recommendations for infants and children. Am J Clin Nutr 80:1759S–1762SPubMed
12.
Zurück zum Zitat Heinig MJ (2003) Vitamin D and the breastfed infant: controversies and concerns. J Hum Lact 19:247–249CrossRefPubMed Heinig MJ (2003) Vitamin D and the breastfed infant: controversies and concerns. J Hum Lact 19:247–249CrossRefPubMed
14.
Zurück zum Zitat Holick MF (2008) The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med 29:361–368CrossRefPubMed Holick MF (2008) The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med 29:361–368CrossRefPubMed
15.
Zurück zum Zitat Holick MF, Shao Q, Liu WW, Chen TC (1992) The vitamin D content of fortified milk and infant formula. N Engl J Med 326:1178–1181CrossRefPubMed Holick MF, Shao Q, Liu WW, Chen TC (1992) The vitamin D content of fortified milk and infant formula. N Engl J Med 326:1178–1181CrossRefPubMed
16.
Zurück zum Zitat Hollis BW, Pittard WB 3rd, Reinhardt TA (1986) Relationships among vitamin D, 25-hydroxyvitamin D, and vitamin D-binding protein concentrations in the plasma and milk of human subjects. J Clin Endocrinol Metab 62:41–44CrossRefPubMed Hollis BW, Pittard WB 3rd, Reinhardt TA (1986) Relationships among vitamin D, 25-hydroxyvitamin D, and vitamin D-binding protein concentrations in the plasma and milk of human subjects. J Clin Endocrinol Metab 62:41–44CrossRefPubMed
17.
Zurück zum Zitat Lazol JP, Cakan N, Kamat D (2008) 10-year case review of nutritional rickets in Children’s Hospital of Michigan. Clin Pediatr (Phila) 47:379–384CrossRef Lazol JP, Cakan N, Kamat D (2008) 10-year case review of nutritional rickets in Children’s Hospital of Michigan. Clin Pediatr (Phila) 47:379–384CrossRef
18.
Zurück zum Zitat Lyke KE, Burges R, Cissoko Y et al (2004) Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 72:5630–5637CrossRefPubMed Lyke KE, Burges R, Cissoko Y et al (2004) Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Infect Immun 72:5630–5637CrossRefPubMed
19.
Zurück zum Zitat Mahajan B, Vijayan VK, Agarwal MK, Bansal SK (2008) Serum interleukin-1beta as a marker for differentiation of asthma and chronic obstructive pulmonary disease. Biomarkers 13:713–727CrossRefPubMed Mahajan B, Vijayan VK, Agarwal MK, Bansal SK (2008) Serum interleukin-1beta as a marker for differentiation of asthma and chronic obstructive pulmonary disease. Biomarkers 13:713–727CrossRefPubMed
20.
Zurück zum Zitat Mattes J, Foster PS (2003) Regulation of eosinophil migration and Th2 cell function by IL-5 and eotaxin. Curr Drug Targets Inflamm Allergy 2:169–174CrossRefPubMed Mattes J, Foster PS (2003) Regulation of eosinophil migration and Th2 cell function by IL-5 and eotaxin. Curr Drug Targets Inflamm Allergy 2:169–174CrossRefPubMed
21.
Zurück zum Zitat Namgung R, Tsang RC, Lee C et al (1998) Low total body bone mineral content and high bone resorption in Korean winter-born versus summer-born newborn infants. J Pediatr 132:421–425CrossRefPubMed Namgung R, Tsang RC, Lee C et al (1998) Low total body bone mineral content and high bone resorption in Korean winter-born versus summer-born newborn infants. J Pediatr 132:421–425CrossRefPubMed
22.
Zurück zum Zitat Park MJ, Namgung R, Kim DH, Tsang RC (1998) Bone mineral content is not reduced despite low vitamin D status in breast milk-fed infants versus cow’s milk based formula-fed infants. J Pediatr 132:641–645CrossRefPubMed Park MJ, Namgung R, Kim DH, Tsang RC (1998) Bone mineral content is not reduced despite low vitamin D status in breast milk-fed infants versus cow’s milk based formula-fed infants. J Pediatr 132:641–645CrossRefPubMed
23.
Zurück zum Zitat Pettifor J (2008) Vitamin D &/or calcium deficiency rickets in infants & children: a global perspective. Indian J Med Res 127:245–249PubMed Pettifor J (2008) Vitamin D &/or calcium deficiency rickets in infants & children: a global perspective. Indian J Med Res 127:245–249PubMed
24.
Zurück zum Zitat Rotondi M, Lazzeri E, Romagnani P, Serio M (2003) Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest 26:177–180PubMed Rotondi M, Lazzeri E, Romagnani P, Serio M (2003) Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest 26:177–180PubMed
25.
Zurück zum Zitat Schmidt-Weber CB, Akdis M, Akdis CA (2007) TH17 cells in the big picture of immunology. J Allergy Clin Immunol 120:247–254CrossRefPubMed Schmidt-Weber CB, Akdis M, Akdis CA (2007) TH17 cells in the big picture of immunology. J Allergy Clin Immunol 120:247–254CrossRefPubMed
26.
Zurück zum Zitat Shaikh U, Alpert PT (2004) Practices of vitamin D recommendation in Las Vegas, Nevada. J Hum Lact 20:56–61CrossRefPubMed Shaikh U, Alpert PT (2004) Practices of vitamin D recommendation in Las Vegas, Nevada. J Hum Lact 20:56–61CrossRefPubMed
27.
Zurück zum Zitat Spach KM, Nashold FE, Dittel BN, Hayes CE (2006) IL-10 signaling is essential for 1, 25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 177:6030–6037PubMed Spach KM, Nashold FE, Dittel BN, Hayes CE (2006) IL-10 signaling is essential for 1, 25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 177:6030–6037PubMed
28.
Zurück zum Zitat Tomoum HY, Badawy NM, Mostafa AA, Harb MY (2007) Plasma interleukin-1beta levels in children with febrile seizures. J Child Neurol 22:689–692CrossRefPubMed Tomoum HY, Badawy NM, Mostafa AA, Harb MY (2007) Plasma interleukin-1beta levels in children with febrile seizures. J Child Neurol 22:689–692CrossRefPubMed
29.
Zurück zum Zitat United States (1980) Infant formula act of 1980: an act to amend the federal food, drug and cosmetic act to strengthen the authority under that act to assure the safety and nutrition of infant formulas, and for other purposes. US GPO: Supt. of Docs. US GPO distributor, Washington, DC United States (1980) Infant formula act of 1980: an act to amend the federal food, drug and cosmetic act to strengthen the authority under that act to assure the safety and nutrition of infant formulas, and for other purposes. US GPO: Supt. of Docs. US GPO distributor, Washington, DC
30.
Zurück zum Zitat Wagner CL, Greer FR (2008) Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 122:1142–1152CrossRefPubMed Wagner CL, Greer FR (2008) Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 122:1142–1152CrossRefPubMed
31.
Zurück zum Zitat Wagner CL, Hulsey TC, Fanning D et al (2006) High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med 1:59–70CrossRefPubMed Wagner CL, Hulsey TC, Fanning D et al (2006) High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med 1:59–70CrossRefPubMed
32.
Zurück zum Zitat Wang TT, Nestel FP, Bourdeau V et al (2004) Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909–2912PubMed Wang TT, Nestel FP, Bourdeau V et al (2004) Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909–2912PubMed
33.
Zurück zum Zitat Ward LM, Gaboury I, Ladhani M, Zlotkin S (2007) Vitamin D-deficiency rickets among children in Canada. CMAJ 177:161–166PubMed Ward LM, Gaboury I, Ladhani M, Zlotkin S (2007) Vitamin D-deficiency rickets among children in Canada. CMAJ 177:161–166PubMed
34.
Zurück zum Zitat Weisberg P, Scanlon KS, Li R, Cogswell ME (2004) Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003. Am J Clin Nutr 80:1697S–1705SPubMed Weisberg P, Scanlon KS, Li R, Cogswell ME (2004) Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003. Am J Clin Nutr 80:1697S–1705SPubMed
35.
Zurück zum Zitat Yang L, Grey V (2006) Pediatric reference intervals for bone markers. Clin Biochem 39:561–568CrossRefPubMed Yang L, Grey V (2006) Pediatric reference intervals for bone markers. Clin Biochem 39:561–568CrossRefPubMed
36.
Zurück zum Zitat Ziegler EE, Hollis BW, Nelson SE, Jeter JM (2006) Vitamin D deficiency in breastfed infants in Iowa. Pediatrics 118:603–610CrossRefPubMed Ziegler EE, Hollis BW, Nelson SE, Jeter JM (2006) Vitamin D deficiency in breastfed infants in Iowa. Pediatrics 118:603–610CrossRefPubMed
37.
Zurück zum Zitat Zipitis CS, Akobeng AK (2008) Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 93:512–517CrossRefPubMed Zipitis CS, Akobeng AK (2008) Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 93:512–517CrossRefPubMed
Metadaten
Titel
Prevalence and risk factors for vitamin D deficiency among healthy infants and young children in Sacramento, California
verfasst von
Lisa Liang
Caroline Chantry
Dennis M. Styne
Charles B. Stephensen
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 11/2010
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-010-1226-3

Weitere Artikel der Ausgabe 11/2010

European Journal of Pediatrics 11/2010 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.